Back to HARRIS ASSOCIATES L P HARRIS ASSOCIATES L P

REGNREGN
20 quarters

Position history for HARRIS ASSOCIATES L PHARRIS ASSOCIATES L P's holdings in REGENERON PHARMACEUTICALS

No. Harris Associates exited its REGN (Regeneron Pharmaceuticals) position in Q3 2023. Its Q2 2023 13F listed 878 shares worth $630,878. Harris Associates already held REGN in its Q4 2018 13F, the earliest on record, and held it in 19 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.1B

Total Shares Change

-3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$815.27
0
2023-Q2
Decreased
878
-53.5%
$630,8780.0%$711.82
0
2023-Q1
Decreased
1,886
-97.9%
$1.5M0.0%$813.99
0
2022-Q4
Decreased
89,639
-52.4%
$64.7M0.1%$714.75
0
2022-Q3
Decreased
188,176
-67.7%
$129.6M0.2%$682.43
0
2022-Q2
Decreased
582,626
-46.7%
$344.4M0.5%$585.60
0
2022-Q1
Decreased
1.1M
-17.3%
$763.4M1.0%$691.89
0
2021-Q4
Decreased
1.3M
-0.4%
$834.4M1.3%$625.62
0
2021-Q3
Decreased
1.3M
-8.2%
$802.6M1.3%$599.52
0
2021-Q2
Increased
1.4M
+39.8%
$807.1M1.3%$553.32
66
2021-Q1
Increased
1M
+95.7%
$489M0.8%$468.72
70
2020-Q4
Decreased
528,130
-20.7%
$255.1M0.5%$478.59
0
2020-Q3
Decreased
666,295
-45.7%
$373M0.9%$554.55
0
2020-Q2
Decreased
1.2M
-47.0%
$765.4M1.9%$617.82
0
2020-Q1
Decreased
2.3M
-46.9%
$1.1B3.1%$483.73
0
2019-Q4
Increased
4.4M
+5.4%
$1.6B2.9%$371.97
58
2019-Q3
Increased
4.1M
+5.8%
$1.1B2.2%$274.81
58
2019-Q2
Increased
3.9M
+46.8%
$1.2B2.3%$310.07
75
2019-Q1
Decreased
2.7M
-11.4%
$1.1B2.0%$406.78
0
2018-Q4
First report
3M
-
$1.1B2.3%$370.01
0

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used